Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2015 2
2017 4
2018 5
2019 18
2020 10
2021 10
2022 12
2023 14
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: . Clear all
Page 1
Palliative Radiotherapy for Symptomatic Locally Advanced Breast Cancer.
Hoeltgen L, Meixner E, Hoegen P, Sandrini E, Weykamp F, Forster T, Vinsensia M, Lang K, König L, Arians N, Fremd C, Michel LL, Smetanay K, Schneeweiss A, Wallwiener M, Debus J, Hörner-Rieber J. Hoeltgen L, et al. Among authors: lang k. Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231164537. doi: 10.1177/15330338231164537. Technol Cancer Res Treat. 2023. PMID: 37038619 Free PMC article.
To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes.
Regnery S, Katsigiannopulos E, Hoegen P, Weykamp F, Sandrini E, Held T, Deng M, Eichkorn T, Buchele C, Rippke C, Renkamp CK, König L, Lang K, Thomas M, Winter H, Adeberg S, Klüter S, Debus J, Hörner-Rieber J. Regnery S, et al. Among authors: lang k. Lung Cancer. 2023 May;179:107175. doi: 10.1016/j.lungcan.2023.03.011. Epub 2023 Mar 21. Lung Cancer. 2023. PMID: 36965207
Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification.
Deng MY, Hinz F, Maas SLN, Anil G, Sievers P, Conde-Lopez C, Lischalk J, Rauh S, Eichkorn T, Regnery S, Bauer L, Held T, Meixner E, Lang K, Hörner-Rieber J, Herfarth K, Jones D, Pfister SM, Jungk C, Unterberg A, Wick W, von Deimling A, Debus J, Sahm F, König L. Deng MY, et al. Among authors: lang k. Neurooncol Adv. 2023 May 14;5(1):vdad059. doi: 10.1093/noajnl/vdad059. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37293256 Free PMC article.
Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial.
Meixner E, Wark A, Forster T, Weykamp F, Lang K, König L, Lindel K, Oelmann-Avendano JT, Krisam J, Schneeweiss A, Ellerbrock M, Mielke T, Hörner-Rieber J, Herfarth K, Debus J, Arians N. Meixner E, et al. Among authors: lang k. Radiat Oncol. 2023 Jan 9;18(1):5. doi: 10.1186/s13014-023-02198-4. Radiat Oncol. 2023. PMID: 36624483 Free PMC article. Clinical Trial.
Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases.
Weykamp F, Katsigiannopulos E, Piskorski L, Regnery S, Hoegen P, Ristau J, Renkamp CK, Liermann J, Forster T, Lang K, König L, Rippke C, Buchele C, Debus J, Klüter S, Hörner-Rieber J. Weykamp F, et al. Among authors: lang k. Cancers (Basel). 2022 Dec 8;14(24):6041. doi: 10.3390/cancers14246041. Cancers (Basel). 2022. PMID: 36551527 Free PMC article.
Long-Term Clinical Results of MR-Guided Stereotactic Body Radiotherapy of Liver Metastases.
Weykamp F, Hoegen P, Regnery S, Katsigiannopulos E, Renkamp CK, Lang K, König L, Sandrini E, Meixner E, Rippke C, Buchele C, Liermann J, Debus J, Klüter S, Hörner-Rieber J. Weykamp F, et al. Among authors: lang k. Cancers (Basel). 2023 May 17;15(10):2786. doi: 10.3390/cancers15102786. Cancers (Basel). 2023. PMID: 37345123 Free PMC article.
Individualized 3D-Printed Tissue Retraction Devices for Head and Neck Radiotherapy.
Herpel C, Schwindling FS, Held T, Christ L, Lang K, Schwindling M, Moratin J, Zaoui K, Moutsis T, Plinkert P, Herfarth K, Freudlsperger C, Rammelsberg P, Debus J, Adeberg S. Herpel C, et al. Among authors: lang k. Front Oncol. 2021 Mar 23;11:628743. doi: 10.3389/fonc.2021.628743. eCollection 2021. Front Oncol. 2021. PMID: 33833988 Free PMC article.
Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions.
Held T, Windisch P, Akbaba S, Lang K, Farnia B, Liermann J, Bernhardt D, Plinkert P, Freudlsperger C, Rieken S, Herfarth K, Debus J, Adeberg S. Held T, et al. Among authors: lang k. Radiat Oncol. 2019 Nov 12;14(1):202. doi: 10.1186/s13014-019-1406-x. Radiat Oncol. 2019. PMID: 31718670 Free PMC article.
Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA).
Hassel JC, Schank TE, Smetak H, Mühlbauer J, Salzmann M, Machiraju D, Menzer C, Lang K, König L, Haefner MF, Hülsmeyer I, Kohler C, Spang R, Enk A, Debus J, Beckhove P. Hassel JC, et al. Among authors: lang k. Oncoimmunology. 2022 Apr 16;11(1):2066609. doi: 10.1080/2162402X.2022.2066609. eCollection 2022. Oncoimmunology. 2022. PMID: 35481285 Free PMC article.
69 results